TNYA
Tenaya Therapeutics, Inc. Common Stock
Healthcare •
Biotechnology •
stocks •
XNAS
• usd
$0.84
$-0.07
(-7.92%)
Loading...
SMA 20: -
SMA 50: -
SMA 200: -
| General | Valuation | Profitability | Financial Health | Trading | Ownership |
|---|---|---|---|---|---|
| Market Cap | $182.32M | EPS (ttm) | $-0.75 | Current Price | $0.84 |
| Enterprise Value | $95.43M | Forward EPS | $-0.46 | Previous Close | $0.91 |
| P/E Ratio | - | ROA | -49.48% | 52W High | $2.35 |
| Forward P/E | -1.82 | ROE | -96.44% | 52W Low | $0.36 |
| PEG Ratio | - | Gross Margin | - | 50 Day Avg | $0.92 |
| P/S Ratio | - | Operating Margin | - | 200 Day Avg | $0.97 |
| P/B Ratio | 1.66 | Profit Margin | - | Volume | 3.19M |
| EV/EBITDA | -1.08 | Current Ratio | 4.64 | Avg Volume | 4.73M |
| EV/Sales | - | Quick Ratio | 4.26 | Beta | 3.19 |
| Employees | 97.00 | Debt/Equity | 13.91 | Shares Outstanding | 216.51M |
| Sector | Healthcare | Total Debt | $11.53M | Float Shares | 120.68M |
| Industry | Biotechnology | Total Cash | $56.31M | Short Float | 20.79% |
| Optionable | Yes | Cash/Share | $0.34 | Short Ratio | 4.90 |
| Dividend Yield | - | Book Value/Share | $0.51 | % Held by Insiders | 0.45% |
| Target Price | $10.00 | Revenue (TTM) | - | % Held by Institutions | 43.37% |